Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:01 PM UTC
| NCT Number | NCT06246916 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 560 participants |
| Active Locations | 104 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06246916 is currently recruiting participants. This phase3 study for melanoma is actively seeking new participants at 104 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06246916 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 104 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06246916 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.